Derma Sciences Reports Fourth Quarter and Year Ended Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- Grand Canyon Education places CFO on leave amid stock trade probe
- Funds sell $44bn in semiconductors on AI concerns
Derma Sciences (DSCI) Tops Q4 EPS by 8c
March 12, 2015 7:31 AM EDTDerma Sciences (NASDAQ: DSCI) reported Q4 EPS of ($0.37), $0.08 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $22.9 million versus the consensus estimate of $22.9 million.
For earnings history and earnings-related data on Derma Sciences (DSCI) click here.
... More